Decheng Capital Management Iii (Cayman), LLC Scynexis Inc Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
A detailed history of Decheng Capital Management Iii (Cayman), LLC transactions in Scynexis Inc stock. As of the latest transaction made, Decheng Capital Management Iii (Cayman), LLC holds 555,555 shares of SCYX stock, worth $905,554. This represents 0.7% of its overall portfolio holdings.
Number of Shares
555,555
Previous 555,555
-0.0%
Holding current value
$905,554
Previous $1.64 Million
22.71%
% of portfolio
0.7%
Previous 0.87%
Shares
1 transactions
Others Institutions Holding SCYX
# of Institutions
58Shares Held
14.5MCall Options Held
34KPut Options Held
5K-
Federated Hermes, Inc. Pittsburgh, PA4.21MShares$6.87 Million0.02% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$3.65 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$2.75 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$2.36 Million0.14% of portfolio
-
D.A. Davidson & Co.549KShares$895,2250.01% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $53.2M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...